G-CSF STARTED ON DAY-MYELOABLATIVE CHEMOTHERAPY (CT) WITH STEM-CELL SUPPORT, BUT NOT AFTER MYELOABLATIVE REGIMENS WITH AUTOLOGOUS STEM-CELLTRANSPLANTATION (ASCT)(1 SHORTENS THE DURATION OF LEUKOCYTOPENIA AFTER SEQUENTIAL NON)

Authors
WANDT H SCHAFER K GOTTLER B BIRKMANN J GALLMEIER WM
Citation
H. Wandt et al., G-CSF STARTED ON DAY-MYELOABLATIVE CHEMOTHERAPY (CT) WITH STEM-CELL SUPPORT, BUT NOT AFTER MYELOABLATIVE REGIMENS WITH AUTOLOGOUS STEM-CELLTRANSPLANTATION (ASCT)(1 SHORTENS THE DURATION OF LEUKOCYTOPENIA AFTER SEQUENTIAL NON), Bone marrow transplantation, 21, 1998, pp. 362-362
Citations number
NO
Categorie Soggetti
Hematology,Oncology,Immunology,Transplantation
Journal title
Bone marrow transplantation → ACNP
ISSN journal
02683369
Volume
21
Year of publication
1998
Supplement
1
Pages
362 - 362
Database
ISI
SICI code
0268-3369(1998)21:<362:GSODC(>2.0.ZU;2-4